Autoimmune hepatitis after high-dose intravenous glucocorticoids for Graves' orbitopathy.

作者信息

Cosentino G, Comi S, Coco B, Marinò M

机构信息

Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy.

Hepatology Unit, University Hospital of Pisa, Pisa, Italy.

出版信息

J Endocrinol Invest. 2023 Apr;46(4):849-850. doi: 10.1007/s40618-023-02029-z. Epub 2023 Feb 2.

DOI:10.1007/s40618-023-02029-z

PMID:36732467

Abstract

摘要

相似文献

Autoimmune hepatitis after high-dose intravenous glucocorticoids for Graves' orbitopathy.

J Endocrinol Invest. 2023 Apr;46(4):849-850. doi: 10.1007/s40618-023-02029-z. Epub 2023 Feb 2.

Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.静脉注射糖皮质激素治疗格雷夫斯眼病后出现的急性肝损伤。

Endocrine. 2016 Oct;54(1):259-268. doi: 10.1007/s12020-016-0928-3. Epub 2016 Mar 22.

The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function.静脉注射糖皮质激素治疗格雷夫斯眼眶病对肾上腺功能的影响。

Endokrynol Pol. 2017;68(4):430-433. doi: 10.5603/EP.a2017.0036. Epub 2017 Jun 12.

Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?中重度格雷夫斯眼病的皮质类固醇治疗：口服还是静脉治疗？

Int J Environ Res Public Health. 2019 Jan 8;16(1):155. doi: 10.3390/ijerph16010155.

Novel observational study protocol to develop a prediction model that identifies patients with Graves' ophthalmopathy insensitive to intravenous glucocorticoids pulse therapy.一项新的观察性研究方案，旨在开发一种预测模型，以识别对静脉注射糖皮质激素脉冲治疗不敏感的 Graves 眼病患者。

BMJ Open. 2021 Dec 16;11(12):e053173. doi: 10.1136/bmjopen-2021-053173.

Clinical review: Intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity.临床综述：静脉内给予糖皮质激素治疗格雷夫斯眼病：疗效和发病率。

J Clin Endocrinol Metab. 2011 Feb;96(2):320-32. doi: 10.1210/jc.2010-1962. Epub 2011 Jan 14.

Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?静脉注射糖皮质激素的早期反应能否预测中重度活动性格雷夫斯眼眶病患者的最终结局？

J Endocrinol Invest. 2017 May;40(5):547-553. doi: 10.1007/s40618-017-0608-z. Epub 2017 Feb 7.

Natural history of graves' orbitopathy after treatment.治疗后格雷夫斯眼眶病的自然病程。

Endocrine. 2017 Aug;57(2):226-233. doi: 10.1007/s12020-016-1136-x. Epub 2016 Oct 5.

Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.他汀类药物并非与格雷夫斯眼眶病静脉注射糖皮质激素冲击疗法相关的肝损伤的危险因素。

J Endocrinol Invest. 2016 Nov;39(11):1323-1327. doi: 10.1007/s40618-016-0518-5. Epub 2016 Jul 27.

Adrenal reserve following treatment of Graves' orbitopathy with intravenous glucocorticoids.静脉注射糖皮质激素治疗格雷夫斯眼眶病后的肾上腺储备。

Thyroid. 2015 Apr;25(4):462-3. doi: 10.1089/thy.2014.0533. Epub 2015 Feb 12.

本文引用的文献

Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathy.格雷夫斯病和格雷夫斯眼病中的抗核自身抗体。

J Endocrinol Invest. 2023 Feb;46(2):337-344. doi: 10.1007/s40618-022-01906-3. Epub 2022 Aug 27.

The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.2021 年欧洲 Graves 眼病专家组（EUGOGO）Graves 眼病医学管理临床实践指南。

Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479.

Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy.年龄和剂量是与 Graves 眼病静脉内糖皮质激素冲击治疗相关肝损伤的主要危险因素。

Thyroid. 2015 Jul;25(7):846-50. doi: 10.1089/thy.2015.0061. Epub 2015 Jun 19.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验